0000000000322843

AUTHOR

C. Brechot

showing 2 related works from this author

Clinical significance of the polymerase chain reaction (PCR) assay in chronic HBV carriers

1992

PCR was evaluated as a clinical tool for use in accurate identification of the specific etiologic agent in chronic HBV carriers. The method was found to be valuable in diagnosis and for monitoring therapy, as well as for elucidation of genotypic variants of HBV in chronic HBV cases. By this means an HBV defective variant with alterations in the preSl/preS2 sequence was detected and is consequently described here.

lawGenotypePcr assayvirus diseasesClinical significanceHbsag carrierBiologyVirologyMolecular biologydigestive system diseasesPolymerase chain reactionlaw.inventionSequence (medicine)
researchProduct

Biological standards for hepatitis B virus assays.

1992

Hepatitis B virusImmunoblottingBiologymedicine.disease_causePolymerase Chain ReactionVirusSerologylaw.inventionlawmedicineHumansHepatitis B AntibodiesPolymerase chain reactionHepatitis B virusHepatologyNucleic Acid HybridizationHepatitis BReference Standardsbiology.organism_classificationmedicine.diseaseHepatitis BVirologyIn vitroHepadnaviridaeDNA ViralViral diseaseJournal of hepatology
researchProduct